Cargando…
Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
BACKGROUND: Heterozygous copy-number and missense variants in CNTNAP2 and NRXN1 have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia. Recently, homozygous or compound heterozygous d...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162517/ https://www.ncbi.nlm.nih.gov/pubmed/21827697 http://dx.doi.org/10.1186/1471-2350-12-106 |
_version_ | 1782210819699769344 |
---|---|
author | Gregor, Anne Albrecht, Beate Bader, Ingrid Bijlsma, Emilia K Ekici, Arif B Engels, Hartmut Hackmann, Karl Horn, Denise Hoyer, Juliane Klapecki, Jakub Kohlhase, Jürgen Maystadt, Isabelle Nagl, Sandra Prott, Eva Tinschert, Sigrid Ullmann, Reinhard Wohlleber, Eva Woods, Geoffrey Reis, André Rauch, Anita Zweier, Christiane |
author_facet | Gregor, Anne Albrecht, Beate Bader, Ingrid Bijlsma, Emilia K Ekici, Arif B Engels, Hartmut Hackmann, Karl Horn, Denise Hoyer, Juliane Klapecki, Jakub Kohlhase, Jürgen Maystadt, Isabelle Nagl, Sandra Prott, Eva Tinschert, Sigrid Ullmann, Reinhard Wohlleber, Eva Woods, Geoffrey Reis, André Rauch, Anita Zweier, Christiane |
author_sort | Gregor, Anne |
collection | PubMed |
description | BACKGROUND: Heterozygous copy-number and missense variants in CNTNAP2 and NRXN1 have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia. Recently, homozygous or compound heterozygous defects in either gene were reported as causative for severe intellectual disability. METHODS: 99 patients with severe intellectual disability and resemblance to Pitt-Hopkins syndrome and/or suspected recessive inheritance were screened for mutations in CNTNAP2 and NRXN1. Molecular karyotyping was performed in 45 patients. In 8 further patients with variable intellectual disability and heterozygous deletions in either CNTNAP2 or NRXN1, the remaining allele was sequenced. RESULTS: By molecular karyotyping and mutational screening of CNTNAP2 and NRXN1 in a group of severely intellectually disabled patients we identified a heterozygous deletion in NRXN1 in one patient and heterozygous splice-site, frameshift and stop mutations in CNTNAP2 in four patients, respectively. Neither in these patients nor in eight further patients with heterozygous deletions within NRXN1 or CNTNAP2 we could identify a defect on the second allele. One deletion in NRXN1 and one deletion in CNTNAP2 occurred de novo, in another family the deletion was also identified in the mother who had learning difficulties, and in all other tested families one parent was shown to be healthy carrier of the respective deletion or mutation. CONCLUSIONS: We report on patients with heterozygous defects in CNTNAP2 or NRXN1 associated with severe intellectual disability, which has only been reported for recessive defects before. These results expand the spectrum of phenotypic severity in patients with heterozygous defects in either gene. The large variability between severely affected patients and mildly affected or asymptomatic carrier parents might suggest the presence of a second hit, not necessarily located in the same gene. |
format | Online Article Text |
id | pubmed-3162517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31625172011-08-27 Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 Gregor, Anne Albrecht, Beate Bader, Ingrid Bijlsma, Emilia K Ekici, Arif B Engels, Hartmut Hackmann, Karl Horn, Denise Hoyer, Juliane Klapecki, Jakub Kohlhase, Jürgen Maystadt, Isabelle Nagl, Sandra Prott, Eva Tinschert, Sigrid Ullmann, Reinhard Wohlleber, Eva Woods, Geoffrey Reis, André Rauch, Anita Zweier, Christiane BMC Med Genet Research Article BACKGROUND: Heterozygous copy-number and missense variants in CNTNAP2 and NRXN1 have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia. Recently, homozygous or compound heterozygous defects in either gene were reported as causative for severe intellectual disability. METHODS: 99 patients with severe intellectual disability and resemblance to Pitt-Hopkins syndrome and/or suspected recessive inheritance were screened for mutations in CNTNAP2 and NRXN1. Molecular karyotyping was performed in 45 patients. In 8 further patients with variable intellectual disability and heterozygous deletions in either CNTNAP2 or NRXN1, the remaining allele was sequenced. RESULTS: By molecular karyotyping and mutational screening of CNTNAP2 and NRXN1 in a group of severely intellectually disabled patients we identified a heterozygous deletion in NRXN1 in one patient and heterozygous splice-site, frameshift and stop mutations in CNTNAP2 in four patients, respectively. Neither in these patients nor in eight further patients with heterozygous deletions within NRXN1 or CNTNAP2 we could identify a defect on the second allele. One deletion in NRXN1 and one deletion in CNTNAP2 occurred de novo, in another family the deletion was also identified in the mother who had learning difficulties, and in all other tested families one parent was shown to be healthy carrier of the respective deletion or mutation. CONCLUSIONS: We report on patients with heterozygous defects in CNTNAP2 or NRXN1 associated with severe intellectual disability, which has only been reported for recessive defects before. These results expand the spectrum of phenotypic severity in patients with heterozygous defects in either gene. The large variability between severely affected patients and mildly affected or asymptomatic carrier parents might suggest the presence of a second hit, not necessarily located in the same gene. BioMed Central 2011-08-09 /pmc/articles/PMC3162517/ /pubmed/21827697 http://dx.doi.org/10.1186/1471-2350-12-106 Text en Copyright ©2011 Gregor et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Gregor, Anne Albrecht, Beate Bader, Ingrid Bijlsma, Emilia K Ekici, Arif B Engels, Hartmut Hackmann, Karl Horn, Denise Hoyer, Juliane Klapecki, Jakub Kohlhase, Jürgen Maystadt, Isabelle Nagl, Sandra Prott, Eva Tinschert, Sigrid Ullmann, Reinhard Wohlleber, Eva Woods, Geoffrey Reis, André Rauch, Anita Zweier, Christiane Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 |
title | Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 |
title_full | Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 |
title_fullStr | Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 |
title_full_unstemmed | Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 |
title_short | Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 |
title_sort | expanding the clinical spectrum associated with defects in cntnap2 and nrxn1 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162517/ https://www.ncbi.nlm.nih.gov/pubmed/21827697 http://dx.doi.org/10.1186/1471-2350-12-106 |
work_keys_str_mv | AT gregoranne expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT albrechtbeate expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT baderingrid expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT bijlsmaemiliak expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT ekiciarifb expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT engelshartmut expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT hackmannkarl expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT horndenise expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT hoyerjuliane expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT klapeckijakub expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT kohlhasejurgen expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT maystadtisabelle expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT naglsandra expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT protteva expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT tinschertsigrid expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT ullmannreinhard expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT wohllebereva expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT woodsgeoffrey expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT reisandre expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT rauchanita expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 AT zweierchristiane expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1 |